Statistics

Total Visits

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis94

Select a period of time:

Number of views in the range

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis26

Views

Views
December 20250
January 20261
February 20261
March 20260
April 20268
May 202613
June 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Spain4
Netherlands2
United Kingdom2
Colombia1
Algeria1
Ecuador1
Finland1
France1
Italy1
 

Top cities views

Views
Madrid3
Los Angeles2
Bedford1
Chattanooga1
Conil de la Frontera1
Ghardaïa1
Groningen1
Helsinki1
Hoofddorp1
Las Vegas1